Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05QHO
|
|||
| Former ID |
DIB016957
|
|||
| Drug Name |
ACE-527
|
|||
| Synonyms |
ACAM-2023; ACAM-2025; ACAM-2027; ACE-537; ETEC vaccine, Acambis; Enterotoxigenic E coli vaccine, Acambis; PTL-002; PTL-003; Travellers vaccine, Acambis; HolaVax-ETEC vaccine, ACE BioSciences; HolaVax-ETEC vaccine, Acambis; HolaVax-ETEC vaccine, Cambridge Stability
Click to Show/Hide
|
|||
| Indication | Escherichia coli infection [ICD-11: 1A03; ICD-10: A04, A04.4] | Phase 2 | [1] | |
| Company |
Glaxo Wellcome plc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01060748) Safety and Efficacy Study of a Vaccine Against Enterotoxigenic Escherichia Coli (ETEC) to Prevent Moderate to Severe Diarrhea. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.